Enlarged Prostate Treatment Options
Struggling with BPH symptoms (benign prostatic hyperplasia)?
Knowing about common BPH treatments can help when talking with your doctor about your concerns.
How BPH Treatment Options Stack Up
The treatment plan you and doctor decide on will likely be influenced by many factors, including quality of life, importance of certain activities, potential side effects, and level of risk involved. See how typical BPH treatment options align with common treatment goals.
Which goals are most important to you?
| Treatment Goal |
Medications1–5 | UroLift® System Procedure6–11 |
Water Vapor Therapy12–15 |
Laser/TURP1,16–18 |
|---|---|---|---|---|
| Minimally invasive treatment that addresses prostate blockage | N/A |
Reduces blockage. Can be performed in a doctor's office with local anesthesia |
Reduces blockage. Can be performed in a doctor's office with local anesthesia |
Reduces blockage. Typically done in a hospital or surgery center with increased anesthesia |
| Quick recoverya | N/A |
88–100% reported little or no interference at ~1 month |
50–60% reported little or no interference at ~1 month |
DATA NOT AVAILABLE |
| Minimal catheter use after procedureb | N/A |
10–32% catheter ratec |
75–100% catheter rate |
~100% catheter rate |
| Low risk of serious complications |
Floppy iris syndrome |
3–7% urinary infection |
7–17% urinary infection |
10–20% urinary infection |
| Sexual preservation |
3–5% erectile dysfunction, |
0% erectile dysfunction, |
0% erectile dysfunction, |
7–10% erectile dysfunction, |
| One-time treatment without ongoing side effects |
Daily requirement to take medications with associated side effects such as headaches, dizziness, lack of energy, insomnia and nasal congestion while on treatment |
Typically, a one-time procedure with associated side effects such as temporary blood in urine and pain |
Typically, a one-time procedure with associated side effects such as temporary blood in urine and pain |
Typically, a one-time procedure with associated side effects such as temporary blood in urine and pain |
| Significant symptom relief |
4–7pt IPSS at 12 mo |
10–11pt IPSS at 12 mo |
10–11pt IPSS at 12 mo |
~15pt IPSS at 12 mo |
| Long-lasting relief |
Daily pill needed |
2–3% per year retreatment |
1–2% per year retreatment |
1–2% per year retreatment |
Reduces blockage. Can be performed in a doctor's office with local anesthesia
Reduces blockage. Can be performed in a doctor's office with local anesthesia
Reduces blockage. Typically done in a hospital or surgery center with increased anesthesia
88–100% reported little or no interference at ~1 month
50–60% reported little or no interference at ~1 month
AVAILABLE
10–32% catheter ratec
75–100% catheter rate
~100% catheter rate
Floppy iris syndrome
Depression & self-harm
3–7% urinary infection <1% urethral scarring, 0–2% bleedingd, <1% bladder stonese
7–17% urinary infection, 0–4% urethral scarring, 0–1% bleedingd
10–20% urinary infection, 3–7% urethral scarring, 2–6% bleedingd, 0–2% urine leakagef, 0–1% TUR syndrome
3–5% erectile dysfunction, 1–10% ejaculatory dysfunction
0% erectile dysfunction, 0% ejaculatory dysfunctiong
0% erectile dysfunction, 3–20% ejaculatory dysfunction
7–10% erectile dysfunction, 40–60% ejaculatory dysfunction
Daily requirement to take medications with associated side effects such as headaches, dizziness, lack of energy, insomnia and nasal congestion while on treatment
Typically, a one-time procedure with associated side effects such as temporary blood in urine and pain
Typically, a one-time procedure with associated side effects such as temporary blood in urine and pain
Typically, a one-time procedure with associated side effects such as temporary blood in urine and pain
4–7pt IPSS at 12 mo
10–11pt IPSS at 12 mo
10–11pt IPSS at 12 mo
~15pt IPSS at 12 mo
Daily pill needed
2–3% per year retreatment
1–2% per year retreatment
1–2% per year retreatment
a. Recovery is defined as return to normal daily activities with little or no interference (Tutrone, Can J Urol 2020). TURP/Laser not studied with this definition of recovery.
b. Based on patients who underwent a voiding trial.
c. Excludes patients with obstructive median lobes for the UroLift™ System, who are estimated to account for ~5% of the eligible UroLift System population.
d. Includes severe bleeding only (clinically defined as Clavien-Dindo grade IIIb)
e. Patients treated with the post-FDA clearance technique requiring a procedure to specifically remove an implant. This was studied in a clinical trial with >1,400 patients.
f. Urinary leakage due to sudden pressure on the bladder from activities such as exercise, laughing, coughing, sneezing etc. (clinically known as stress urinary incontinence)
g. UroLift System definition of erectile and ejaculatory dysfunction requires new onset and sustained event. Other therapies described have different definitions of sexual preservation.
References
1. AUA BPH Guidelines 2003. Updated 2020.
2. McConnell, N Engl J med 2003;349:2387-98
3. Chang DF, Campbell JR, J Cataract Refract Surg. 2005 Apr; 31(4): 664-673
4. Duan et al, Pharmacoepidemiol Drug Saf. 2018 Mar; 27(3): 340-348
5. Welk et al, JAMA Intern Med. 2017 May 1; 177(5): 683-691
6. Roehrborn, J Urol 2013; 190(6): 2161-7
7. Roehrborn, Can J Urol 2017; 24(3): 8802-8813
8. Shore Can J Urol 2014
9. Tutrone, Can J Urol 2020
10. Eure, et al., AUA 2020
11. Sonksen, et al., Eur Urol 2015 Oct; 68(4): 643-52
12. McVary, J Urol 2016; 195(5):1529-1538
13. McVary, J Urol 2020; 203(4S): AUA abstract LBA01-06 5-year Rezum
14. Mollengarden, et al., Prostate Cancer Prostatic Dis 2018 Sep; 21(3): 379-385
15. Yang, WCE 2018
16. Bachmann, et al., Eur Urol 2014; 65(5): 931-942
17. Strope, Urology 2015; 86: 1115-1122
18. Rassweiler, et al., Eur Urol 2006; 50(5): 969-980
MAC02259-05A,p5
What are my options?
If you have BPH symptoms that are just not improving, or are getting worse over time, it's important to talk with your urologist.
Medications
These include alpha blockers, which relax bladder neck muscles, and 5-alpha reductase inhibitors which act to shrink the prostate.
UroLift™ System
Small implants are placed to lift or hold excess tissue out of the way so it no longer blocks the urethra – with no heating, cutting, or removal, of prostate tissue.3,4
Thermotherapies
Heat, such as steam or hot water, is applied directly to the prostate to destroy excess tissue.
Laser
Concentrated light is used to generate precise, intense heat to destroy excess prostate tissue.
Waterjet Ablation
A high-velocity waterjet is used to destroy excess prostate tissue, using an image-guided robotic arm.
Transurethral Resection (TURP)
An electric wire loop or laser fiber is used to remove or vaporize excess prostate tissue.
Treating your BPH with medication. If you are diagnosed with BPH, your doctor may prescribe medication. BPH medication typically falls into two categories, alpha blockers and five alpha reductase inhibitors. You may start with one type within a category. If your symptoms do not improve or if bothersome side effects occur, you may be changed to the other category of drug or given a combination of both types of medication. We will discuss these two most common types of medications. However, there are others that your doctor may prescribe to treat your BPH. What's the difference between the two medications? Alpha blockers attempt to relax the smooth muscle in the bladder and prostate, thus increasing urinary flow. Five alpha reductase inhibitors, also known as five ARIs, can reduce prostate volume. For some men, BPH medications are effective, well tolerated, and may adequately address the symptoms of your BPH. Some common downsides of BPH medications include side effects, lack of symptom improvement, ongoing cost, and inconvenience. Long known potential side effects of these BPH medications may include dizziness, headaches, fatigue, sexual side effects, including a decreased sex drive, and enlargement or swelling of breast tissue. Some new research has shown other potential side effects from BPH medications may include an increased risk of stroke, dementia, and depression. Further research is needed. It is important to understand BPH medication does not fix the blockage caused by your enlarged prostate. It only addresses the symptoms. Patients on long term medical therapy often do not adhere to treatment. And if BPH is left untreated, this can lead to poor bladder health. Even if you are taking BPH medication, you may want to speak with your doctor about other treatment options to address your BPH and potentially reduce your reliance on medication.
Learn About Common BPH Medications
The system treatment was a BPH solution for Mike. This BPH treatment does not cut or burn away prostate tissue. Instead, it holds the enlarged prostate tissue out of the way to open the obstructed channel, unblocking the urine flow. It can provide faster recovery and rapid symptom relief with fewer risks than those often associated with traditional surgery. In clinical studies, the UroLift system was shown to preserve sexual function. It can get men off BPH medications and avoid the risk of bothersome side effects. It offered Mike the BPH relief he's been looking for. If you are like Mike and are interested in treating your BPH with the UroLift System, here's what you can expect. Your urologist will examine you to help determine if you are a candidate for the procedure. Your urologist may perform a cystoscopy, which uses a small flexible camera to view your prostate. If the UroLift System is right for you, please ask your urologist how to prepare for the procedure, which may include temporarily discontinuing certain medications. Often, the UroLift System treatment is performed right in your doctor's office or in an outpatient surgical center under local anesthesia. The procedure can also be done in a hospital setting. Your urologist will help you determine the best facility for your treatment and recommend the appropriate post procedure care for you. With the UroLift System, patients typically experience rapid relief from their BPH symptoms with recovery in days, not months, and quickly get back to the things they love. Most common side effects are temporary and can include discomfort when urinating, urgency, inability to control the urge, pelvic pain, and some blood in the urine. Rare side effects, including bleeding and infection, may lead to a serious outcome and may require intervention.
The UroLift System - What to Expect
Don't Hesitate to Ask Your Doctor
Many people aren’t comfortable talking about sensitive health topics, even with their doctor, and may downplay or avoid discussing their worsening urinary issues. Health care professionals, especially urologists, often talk with people about urinary problems, and the good news is, BPH symptoms are generally treatable. Discussing your health concerns is the first step towards finding solutions.
Don't hesitate to ask your doctor about minimally invasive procedures like the UroLift™ System.
You May Need to Ask
Let your doctor know if BPH medications aren't helping enough or if you have concerns about potential side effects. Ask about minimally invasive treatment options that align with your treatment goals.
75%
Surveyed said they weren't informed about minimally invasive procedures as an alternative to BPH medications*
Take Care of #1
Part of the standard of care,6 the UroLift™ System can be used to treat a broad spectrum of anatomies, including lateral and obstructive median lobe and prostates up to 100cc.4,5
#1
The UroLift™ System is the #1 chosen minimally invasive BPH procedure in the U.S.**
Don't Let BPH Hurt Your Sex Life
Patients treated with the UroLift™ System achieved better reported outcomes in sexual function§ and satisfaction than men who received BPH medication.3
57%
Of men surveyed believe that BPH affects their relationships and 61% say it impacts sex*
For procedures
- How fast will I experience BPH symptom relief?
- What level of symptom relief can I expect?
- What are the common side effects?
- What are the anesthesia options; is a hospital stay required?
- Would I go home with a catheter?
- When can I return to normal activity?
For medications
-
What level of symptom relief can I expect?
-
What side effects are typical and are any serious?
-
Will I always need to be on BPH medications and are they known to be effective over time?
-
Will delaying having a procedure increase my risk of bladder or kidney disease?
-
If medications aren't helping enough, what are my options?
My name is Corey James Blessingain. I had BPH for about ten years before I did anything. I started having those symptoms in my early 40s, late 30s, where I noticed that I would have to get up in the middle of the night to go to the bathroom. I want to say ten years. I kind of lived that life of getting up, going to the bathroom in the middle of the night, not being able to travel far because I needed to be around the bathroom, being careful of how much liquids I drank. So that's kind of my early stages of BPH. I was living in my hometown or where I grew up at, New York City, and they didn't have anything that was beneficial or that I thought I would want to do. I didn't like the invasive procedures that they were talking about. I then moved to Pennsylvania and got a new urologist. Speaking with this urologist, within a year, he introduced me to this new procedure called the UroLift. And I stepped out on what we call FAITH, and I did it. Within a week, I drove to New York, and I did not have to stop. I was able to travel and not have to pull over and I've been leakage free for a while. I became a UroLift System Ambassador because it gave me my life back and I felt that everyone should have their life and live it to the fullest. The advice I would give to men who are experiencing BPH is not to sit around and think it's going to go away. It doesn't go away on its own. Go check. Go get yourself checked out.
"The advice I would give to men who experience BPH is not to sit around and think it's going to go away...go get yourself checked out." ‡
- Corey B, Age 52
Frequently Asked Questions (FAQs)
How Long Do UroLift Implants Usually Last?
Our pivotal study with the Urolift System treatment has reported durable outcomes out to 5 years.1 A real-world study found that 88.4% of UroLift patients did not require a secondary surgical procedure through 5-years2.
See PublicationsIs the UroLift procedure permanent, and can the implants be removed if needed?
The UroLift System implant is designed to be a permanent implant. The UroLift implants are made from standard surgical materials and have been tested for biocompatibility.
A real-world study showed that 88.4% of patients receiving the UroLift System treatment did not need a second surgical treatment through 5-years.2
The UroLift System treatment does not prevent future UroLift System, TURP, or laser procedures if recommended by your physician.1
How does the UroLift System treatment compare to other treatment options?
The UroLift™ System is the only leading BPH MIST* with consistent durability in a controlled trial and real-world setting.1,2,3 The UroLift™ System is a comprehensively studied minimally invasive BPH procedure, with over 145 peer-reviewed and 22 sponsored publications.
The UroLift procedure is a minimally invasive procedure which can be performed as a same day outpatient procedure, including the office setting, under local anesthesia.4 The UroLift™ system treatment is a minimally invasive procedure, it has rapid symptom relief and recovery.4,5
References:
*Rezūm™, UroLift™ System 1. Roehrborn, Can J Urol 2017 2. Kaplan, Prostate Cancer Prostatic Dis 2023 3. U.S. 2023 estimates based on US Market Model 2023-25 (3-14-23 FINAL), which is in part based on Symphony Health PatientSource® 2018-22, as is and with no representations/warranties, including accuracy or completeness. 4. Shore, Can J Urol 2014 5. Roehrborn, J Urology 2013 MAC03242-08 Rev A
References
1. Roehrborn, J Urology 2013
2. AUA Guidelines 2003, 2020
3. Roehrborn, Eur Urol Focus 2021
4. Rukstalis, Prostate Cancer Prostatic Dis 2018
4. UroLift System Instructions for Use
5. AUA BPH Guidelines, 2021
† As with any medical procedure, individual results may vary. See patient safety for more information.
*Survey of US men aged 40+ who have been diagnosed with BPH (enlarged prostate) and are/have been treated with BPH medications, conducted by Teleflex in 2020. Data on file, n=96.
**U.S. 2022 estimates based on US Market Model 2022-24 (5-17-22 FINAL), which is in part based on Symphony Health PatientSource® 2018-21, as is and with no representations / warranties, including accuracy or completeness.
§ Based on an indirect comparison of erectile and ejaculatory function and sexual satisfaction in men who received PUL in controlled studies or in men who received medical therapy in the MTOPS study.
MAC11000-02 Rev A